Dupilumab with concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: A randomised, placebo-controlled phase 3 clinical trial (CHRONOS)

被引：0
|
作者：
Blauvelt, A. [1 ]
Gooderham, M. [2 ]
Foley, P. [3 ]
Griffiths, C. E. M. [4 ]
Cather, J. C. [5 ]
de Bruin-Weller, M. [6 ]
Zhu, X. [7 ]
Graham, N. M. H. [8 ]
Pirozzi, G. [9 ]
Shumel, B. [8 ]
机构：
[1] Oregon Med Res, Portland, OR USA
[2] SKiN Ctr Dermatol, Peterborough, ON, Canada
[3] Univ Melbourne, Skin & Canc Fdn Inc, Carlton, Vic, Australia
[4] Univ Manchester, Salford Royal Hosp, Dermatol Ctr, Manchester, Lancs, England
[5] Modern Dermatol Modern Res Associates, Dallas, TX USA
[6] Univ Med Ctr Utrecht, Utrecht, Netherlands
[7] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA
[8] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Bridgewater, NJ USA
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of dupilumab with concomitant topical corticosteroids for up to 1 year in moderate-to-severe atopic dermatitis: a randomized, placebo-controlled phase III trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Soo, Y.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 10 - 10
  • [2] LONG-TERM MANAGEMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB AND CONCOMITANT TOPICAL CORTICOSTEROIDS: A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Zhu, X.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 25 - 25
  • [3] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Gooderham, Melinda
    Cather, Jennifer C.
    Weisman, Jamie
    Pariser, David
    Simpson, Eric L.
    Papp, Kim A.
    Hong, H. Chih-Ho
    Rubel, Diana
    Foley, Peter
    Prens, Errol
    Griffiths, Christopher E. M.
    Etoh, Takafumi
    Pinto, Pedro Herranz
    Pujol, Ramon M.
    Szepietowski, Jacek C.
    Ettler, Karel
    Kemeny, Lajos
    Zhu, Xiaoping
    Akinlade, Bolanle
    Hultsch, Thomas
    Mastey, Vera
    Gadkari, Abhijit
    Eckert, Laurent
    Amin, Nikhil
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Stahl, Neil
    Yancopoulos, George D.
    Shumel, Brad
    [J]. LANCET, 2017, 389 (10086): : 2287 - 2303
  • [4] Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study
    Ebisawa, Motohiro
    Kataoka, Yoko
    Tanaka, Akio
    Nagao, Mizuho
    Laws, Elizabeth
    Mortensen, Eric
    Nawata, Hisakatsu
    Arima, Kazuhiko
    Watanabe, Daisuke
    Lu, Xin
    Maloney, Jennifer
    Dubost-Brama, Ariane
    Bansal, Ashish
    Yahata, Kenji
    [J]. ALLERGOLOGY INTERNATIONAL, 2024, 73 (04) : 532 - 542
  • [5] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal
    Thomson, J.
    Wernham, A. G. H.
    Williams, H. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) : 897 - 902
  • [6] Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 3, Randomized, Placebo-Controlled Trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 61 - 61
  • [7] Dupilumab with concomitant topical corticosteroids promotes rapid and sustained improvement in clinical signs in patients with moderate to severe atopic dermatitis: LIBERTY AD CHRONOS trial
    Blauvelt, Andrew
    Bieber, Thomas
    Weisman, Jamie
    Chen, Zhen
    Shumel, Brad
    Rossi, Ana Beatris
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB146 - AB146
  • [8] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Zhao, Yan
    Wu, Liming
    Lu, Qianjin
    Gao, Xinghua
    Zhu, Xiaohong
    Yao, Xu
    Li, Linfeng
    Li, Wei
    Ding, Yangfeng
    Song, Zhiqiang
    Liu, Lingling
    Dang, Ningning
    Zhang, Chunlei
    Liu, Xiaoming
    Gu, Jun
    Wang, Jinyan
    Geng, Songhai
    Liu, Qunazhong
    Guo, Yifeng
    Lv, Dong
    Ren, Gong
    Yang, Xiumin
    Deng, Danqi
    Li, Shanshan
    Han, Xiuping
    Biao, Shuzhen
    Zheng, Min
    Dong, Li
    Su, Huijuan
    Bai, Lili
    O'Malley, John T.
    Luo, Junxiang
    Zhang, Jianzhong
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
  • [9] Efficacy and safety of lebrikizumab in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis: a phase III randomized, placebo-controlled trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E108 - E108
  • [10] Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
    Thaci, Diamant
    Simpson, Eric L.
    Beck, Lisa A.
    Bieber, Thomas
    Blauvelt, Andrew
    Papp, Kim
    Soong, Weily
    Worm, Margitta
    Szepietowski, Jacek C.
    Sofen, Howard
    Kawashima, Makoto
    Wu, Richard
    Weinstein, Steven P.
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Teper, Ariel
    Sutherland, E. Rand
    Mastey, Vera
    Stahl, Neil
    Yancopoulos, George D.
    Ardeleanu, Marius
    [J]. LANCET, 2016, 387 (10013): : 40 - 52
12345